Skip to content

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

  • Home
  • About US
  • Bioinsight
  • Policy Hub
  • Deals Book
  • Privacy Policy
  • Contact US

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

Company Deals

Apeloa Pharmaceutical and METiS Therapeutics Announce Strategic CDMO Partnership

Fineline Cube Aug 4, 2026
Company Deals

ELI Radiopharma and United Imaging Research Institute Forge Strategic Alliance to Advance Radiopharmaceutical Innovation

Fineline Cube Aug 4, 2026
Company Deals

Qyuns Therapeutics’ Partner Caldera to Merge with Synlogic in $278M Backed Deal, Advancing TL1A/IL-23p19 Bispecific Antibody for Inflammatory Bowel Disease

Fineline Cube Jul 30, 2026
Company Deals

China Resources Pharmaceutical to Acquire Lier Chemical for $795M in Strategic Move into Agrochemical Sector

Fineline Cube Jul 30, 2026
Company Deals

TPMeds Secures Tens of Millions in RMB Angel Round Led by Lotus Lake Ventures to Advance TPM004 IND and PepTetris Platform

Fineline Cube Jul 29, 2026
Drug Medical Device Policy / Regulatory

NMPA Proposes Framework for Synchronized Development of Anti-Tumor Drugs and Companion Diagnostics

Fineline Cube Aug 4, 2026
Company Drug

Sino Biopharmaceutical’s TQB2102 Receives Breakthrough Therapy Designation from NMPA for HER2-Low Breast Cancer

Fineline Cube Aug 4, 2026
Company Drug

Suzhou Forlong Biotechnology Advances FL115 Subcutaneous Injection into Phase 1 Clinical Trial for Advanced Solid Tumors

Fineline Cube Aug 4, 2026
Drug Legal / IP Policy / Regulatory

U.S. Senate Passes Affordable Prescriptions for Patients Act to Limit Patent Thicketing

Fineline Cube Jul 15, 2024

In a significant move to curb drug prices, the U.S. Senate unanimously passed the Affordable...

Company Deals

Nona Biosciences Partners with Alaya.bio to Revolutionize CAR-T Therapy Development

Fineline Cube Jul 15, 2024

Nona Biosciences, a subsidiary of HBM Holdings Ltd (HKG: 2142), has entered into a strategic...

Company Drug

Eisai’s Next-Gen SERD, Orserdu, Begins Real-World Study in Shanghai Ruijin Hospital’s Hainan Subsidiary

Fineline Cube Jul 15, 2024

Shanghai Ruijin Hospital’s Hainan subsidiary has initiated a real-world study for Orserdu (elacestrant), a next-generation...

Company Drug

Everest Medicines’ Velsipity Shows Positive Results in Largest Asian Phase III UC Trial

Fineline Cube Jul 15, 2024

Everest Medicines (HKG: 1952), a leading biopharmaceutical company based in China, has announced positive top-line...

Company Drug

Huadong Medicine’s Partner Arcutis Gets FDA Nod for Roflumilast Cream

Fineline Cube Jul 15, 2024

Huadong Medicine Co., Ltd (SHE: 000963), a Chinese pharmaceutical company, announced that its co-development partner...

Company Deals Medical Device

Mindray Bio-Medical Partners with Nanjing Municipal Government to Boost Healthcare Innovation

Fineline Cube Jul 15, 2024

Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760), a leading player in the global medical...

Company Deals

Shenzhen-Based National Biological Manufacturing Innovation Center Breaks Ground

Fineline Cube Jul 15, 2024

Construction has commenced on a pioneering national biological manufacturing industry innovation center in Shenzhen, marking...

Company Deals Digital

E-Health Now Secures USD 13.8 Million in Series C Financing to Expand AI Medical Services

Fineline Cube Jul 15, 2024

E-Health Now, a China-based one-stop artificial intelligence (AI)-powered medical health service platform, has reportedly secured...

Company

Merck KGaA Launches First GMP Cell Culture Medium Production Line in China

Fineline Cube Jul 15, 2024

German pharmaceutical giant Merck KGaA (ETR: MRK) has announced the commencement of commercial manufacturing of...

Company Deals

AusperBio Secures $37 Million in Series A Funding to Advance Hepatitis B Therapy AHB-137

Fineline Cube Jul 15, 2024

AusperBio, a sino-American biotechnology company specializing in liver therapy development, has reportedly secured USD 37...

Company Drug

Mabwell Bioscience’s 9MW2821 Earns FDA Fast Track Designation for Triple Negative Breast Cancer

Fineline Cube Jul 15, 2024

Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062), a biopharmaceutical company based in China, has announced...

Company Deals

Shanghai Duoning Biotechnology Partners with BASF SE to Commercialize Medical Materials in China

Fineline Cube Jul 15, 2024

Shanghai Duoning Biotechnology Co., Ltd, a prominent player in China’s biopharmaceutical industry, has entered into...

Company Drug

NMPA Accepts 3SBio’s Filing for Anemia Treatment SSS06, Potential Game Changer for Dialysis Patients

Fineline Cube Jul 15, 2024

3SBio Inc. (HKG: 1530), a leading biopharmaceutical company based in China, has announced that the...

Company Deals

Baheal Pharmaceutical Group to Launch Industry Fund Focused on Life Sciences

Fineline Cube Jul 15, 2024

China’s leading health services and distribution conglomerate, Baheal Pharmaceutical Group, is venturing into the investment...

Company Deals Drug

Huadong Medicine Secures Exclusive Rights to Oral Edaravone Candidate TTYP01 in Major Licensing Deal

Fineline Cube Jul 15, 2024

Huadong Medicine Co., Ltd (SHE: 000963), a prominent pharmaceutical company in China, has entered into...

Company Drug

Oricell Therapeutics’ GPRC5D-Targeted CAR-T Therapy Earns FDA Fast Track for Multiple Myeloma

Fineline Cube Jul 15, 2024

Oricell Therapeutics Co., Ltd, a leading biopharmaceutical company based in China, has announced that it...

Company Deals

Legend Biotech’s Shares Leap on Acquisition Rumors; Parent Genscript Biotech Corp. Follows Suit

Fineline Cube Jul 15, 2024

Chinese biopharmaceutical firm Legend Biotech (NASDAQ: LEGN), a specialist in chimeric antigen receptor (CAR) T-cell...

Company R&D

Oxford Study Clears Semaglutide of Neuro/Psychiatric Risks, Suggests Cognitive and Addiction Benefits

Fineline Cube Jul 15, 2024

Researchers at the prestigious Oxford University in the UK have unveiled groundbreaking real-world data on...

Company Drug

Simcere Pharmaceutical’s COVID-19 Therapy Xiannuoxin Earns Full Approval in China

Fineline Cube Jul 12, 2024

Simcere Pharmaceutical Group (HKG: 2096), a biopharmaceutical company based in China, has announced that its...

Company Deals R&D

Beijing Tsingke Biotech Partners with Zhejiang University’s Innovation Center for Nucleic Acid Drug Delivery

Fineline Cube Jul 12, 2024

Beijing Tsingke Biotech Co., Ltd., a prominent player in the DNA/RNA synthesis domain based in...

Posts pagination

1 … 367 368 369 … 702

Recent updates

  • Apeloa Pharmaceutical and METiS Therapeutics Announce Strategic CDMO Partnership
  • Sansure Biotech Secures EU IVDR CE Certification for Five Nucleic Acid Diagnostic Kits
  • Sino Biopharmaceutical’s TQB2102 Receives Breakthrough Therapy Designation from NMPA for HER2-Low Breast Cancer
  • Suzhou Forlong Biotechnology Advances FL115 Subcutaneous Injection into Phase 1 Clinical Trial for Advanced Solid Tumors
  • Shaanxi Micot Pharmaceutical Announces Positive Phase 2 Results for MT200605 in Acute Ischemic Stroke
Special Report 2025 Q1: U.S. Targets Chinese Pharma with 200% Tariffs—Will the Global Drug Market Collapse?

Category

  • Company
  • Deals
  • Digital
  • Drug
  • General/Other
  • Hospital
  • Legal / IP
  • Medical Device
  • Others
  • Policy / Regulatory
  • R&D

You Missed

Company Deals

Apeloa Pharmaceutical and METiS Therapeutics Announce Strategic CDMO Partnership

Company Medical Device

Sansure Biotech Secures EU IVDR CE Certification for Five Nucleic Acid Diagnostic Kits

Company Drug

Sino Biopharmaceutical’s TQB2102 Receives Breakthrough Therapy Designation from NMPA for HER2-Low Breast Cancer

Company Drug

Suzhou Forlong Biotechnology Advances FL115 Subcutaneous Injection into Phase 1 Clinical Trial for Advanced Solid Tumors

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

Copyright © 2025 | Fineline Information & Technology | BlogData by Themeansar.